This MedLibrary.org supplementary page on Fluocinonide is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Fluocinonide
|
|
| Systematic (IUPAC) name | |
| 6α,9-difluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,21-acetate | |
| Identifiers | |
| CAS number | |
| ATC code | C05 D07 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C26H32F2O7 |
| Mol. mass | 494.525 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | hepatic |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | topical |
Fluocinonide (Fluonex, Lidex, Lidex-E, Lonide, and Lyderm) [1] is a potent glucocorticoid steroid used topically as anti-inflammatory agent for the treatment of skin disorders such as eczema. It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort.
The usual prescription concentration is 0.05% as a topical cream, ointment, or gel. The application area should normally not be covered after application. In certain cases, the physician may recommend the use of an occlusive dressing after application in order to increase the rate and depth of absorption. The frequency of application depends on the condition being treated and the area affected, but most often application should occur two times a day.
Fluocinonide ranks as a "high-potency" (second-highest rank) topical corticosteroid. Minimal amounts should be used for a minimal length of time to avoid the occurrence of adverse effects.[2]
Fluocinonide should not be used if infection is present. It should not be applied to the eyes or to sensitive areas such as the genitals or anus.
A common potential adverse effect is skin atrophy (thinning of the skin). Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal axis (HPA) suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients.
Fluocinonide should be used with caution when treating children, pregnant women, nursing mothers, and anyone using the medication for longer than two weeks.
Fluocinonide is also used in veterinary medicine. It is a treatment for allergies in dogs.[3] Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure.[4]
References
- ^ MedlinePlus Drug Information: Fluocinonide Topical
- ^ Disease management of atopic dermatitis: a practice parameter; ANNALS OF ALLERGY, ASTHMA, & IMMUNOLOGY; VOLUME 79, SEPTEMBER, 1997; http://www.jcaai.readyportal.net/file_depot/0-10000000/20000-30000/27387/folder/63948/Atopic_Derm1997.pdf
- ^ Dog Allergies www.squidoo.com/dogallergy
- ^ Adrenocortical suppression by topically applied corticosteroids in healthy dogs. J Am Vet Med Assoc. 1987 Sep 15;191(6):685-8. http://www.ncbi.nlm.nih.gov/pubmed/2824410
|
|||||||||||
Wikipedia content modification information:
- This page was last modified on 6 September 2008, at 02:00.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Fluocinonide".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.